AVXL

ANAVEX LIFE SCIENCES CORP. AVXL

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,858 of 3,068

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Top Institutional Holders

as of Q2 2026
$95.86M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q3 2026
EDGAR

EPS (Diluted)

Q3 2026
EDGAR

ROIC

Q3 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AVXL

Earnings Per Share

13fpro.ai/company/AVXL

Loading ratio trend…

AVXL insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in AVXL

2 transactions in AVXL reported by 1 member of Congress under the STOCK Act, most recent trade Dec 12, 2022. Reported transactions, not recommendations.

All Congress stock trades →

About ANAVEX LIFE SCIENCES CORP. (AVXL): stock profile, AI score and financials

ANAVEX LIFE SCIENCES CORP. (AVXL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AVXL at 24.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,858 of 3,068 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (1.2) and institutional flow (7.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.0/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of AVXL by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, TWO SIGMA INVESTMENTS, based on the most recent SEC filings. AVXL trades on the Nasdaq exchange and files with the SEC under CIK 1314052. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVXL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ANAVEX LIFE SCIENCES CORP. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1314052 →